Evaluating the Use of Recommended Screening and Preventive Practices for Adult Allogeneic Transplant Patient Survivors Performed by Advanced Practice Providers
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This quality improvement project evaluated a new screening template for advanced practice providers (APPs) caring for allogeneic transplant survivors. The template improved screening completion rates, highlighting opportunities for enhanced APP care delivery and patient outcomes.
Area Of Science
- Transplant Medicine
- Quality Improvement Science
- Advanced Practice Provider Care
Background
- Post-transplant care for allogeneic transplant survivors requires adherence to established screening guidelines.
- Advanced Practice Providers (APPs) play a crucial role in managing the complex care needs of these patients.
- Standardization of screening protocols can improve the consistency and quality of care.
Purpose Of The Study
- To evaluate the effectiveness of a posttransplant screening care guidelines template for APPs managing adult allogeneic transplant survivors.
- To assess the integration of institutional standards of care and American Society for Transplantation and Cellular Therapy (ASTCT) recommendations into APP practice.
- To identify areas for improvement in screening completion rates and care delivery.
Main Methods
- A quality improvement project utilized the Model for Improvement with Plan-Do-Study-Act (PDSA) cycles.
- A screening template incorporating ASTCT guidelines and institutional standards was developed within the electronic medical record for APP use.
- Weekly chart reviews over 3 months assessed APP documentation and completion of day +30 and day +100 screenings.
Main Results
- The APPs successfully performed and documented recommended screenings for 64% of patients at day +30 and 80% at day +100.
- The project identified opportunities for system and unit improvements to enhance screening utilization.
- Early identification of complications and potential improvements in patient outcomes were noted.
Conclusions
- The implemented screening template has implications for APP care delivery and patient outcomes in allogeneic transplant survivors.
- Maximizing the APP role within their scope of practice is key to future project success.
- Continuous quality improvement cycles are essential for optimizing post-transplant care.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...